Here, we found that miR-33b significantly mitigated the elevated lipogenesis, lipolysis and β-oxidation activities of ovarian cancer cells in fatty acid-enriched OCM; accordingly, miR-33b inhibited OCM-mediated ovarian cancer cell proliferation and migration/invasion abilities in vitro. The gene discussed is OCM; the disease is ovarian carcinoma.